Since previous attempts to increase cellular Nm23-H1-employing gene and protein therapy or MPA treatment have some limitations in suppressing tumor metastasis, new approaches are required to increase the cellular level of Nm23 as an anti-metastatic agent. Here, NME1 is linked to neoplasm.